ABSTRACT
Streptomyces gilvosporeus strain F607 is a producer of high levels of natamycin used in the fermentation industry. In this study, the complete genome sequence of strain F607 was determined. This genome sequence provides a basis for understanding natamycin biosynthesis and regulation in a high-natamycin-producing strain and will aid in the development of useful strategies for improving industrial strains.
GENOME ANNOUNCEMENT
Natamycin (also known as pimaricin), a potent antifungal compound belonging to the polyene antibiotics, has been widely used as a food additive for nearly 50 years and has been generally regarded as safe (GRAS) by the United States Food and Drug Administration. Furthermore, natamycin plays an important role in antifungal therapy, and it was reported to be an effective agent in treating fungal keratitis and bronchopulmonary aspergillosis (1, 2).
Natamycin was originally isolated from Streptomyces natalensis (3) and is also produced by a variety of soil-dwelling Streptomyces species, such as Streptomyces gilvosporeus (4), Streptomyces chattanoogensis (5), and Streptomyces lydicus (6). The natamycin biosynthesis gene cluster has been partially or entirely sequenced in several streptomycete strains, including in the draft genomes of S. natalensis, S. chattanoogensis, and S. lydicus (7, 8). Studies showed that the natamycin biosynthesis gene clusters in S. natalensis and S. chattanoogensis have high similarity, and both include five large polyketide synthase (PKS) genes and dozens of genes for tailoring enzymes, transport, and regulation (9, 10). Although the natamycin biosynthesis gene cluster from S. gilvosporeus Ins1 has been sequenced (11), no genome sequence of S. gilvosporeus has been reported. Due to the considerable commercial value of natamycin, we present here the first complete genome sequence and genomic features of S. gilvosporeus F607, a high-natamycin-producing industrial strain, which was developed from ATCC 13326 by various mutagens and collected by our laboratory.
The genome of strain F607 was sequenced using the Illumina HiSeq 4000 platform at the Beijing Genomics Institute (Shenzhen, China). After quality control, about 1,219 Mbp of data were obtained, and about 898 Mbp of data were obtained with the PacBio RSII platform. A total of 8,482,298 bp of genome sequence with an average G+C content of 70.95% was assembled; the genome was predicted to contain one linear chromosome, including 7,145 protein-coding genes, 69 tRNAs, 18 rRNAs (5S, 16S, and 23S), 3 noncoding RNAs (ncRNAs), and 287 pseudogenes. The DNA sequence of the natamycin biosynthesis gene cluster was highly similar to those of the corresponding clusters in S. natalensis ATCC 27448, S. chattanoogensis L10, and S. lydicus A02, with 94%, 93%, and 93% identities, respectively. The gene organization within these clusters and regulatory genes also showed high similarity, except that the sgnT gene in strain F607 was on the opposite side of the cluster from the position of its homologues in other species.
In summary, this study presents the first complete genome sequence of S. gilvosporeus, which is used in industry due to its high-natamycin-producing ability. Analysis of the genome shows that genes related to natamycin biosynthesis are highly similar to those in S. natalensis, S. chattanoogensis, and S. lydicus. This genomic study will facilitate an understanding of the molecular mechanisms of natamycin biosynthesis and regulation and enable further genetic engineering studies to enhance the production of natamycin.
Accession number(s).
The genome sequence of S. gilvosporeus strain F607 has been deposited at GenBank under the accession number CP020569.
ACKNOWLEDGMENTS
This work was supported in part by the Shandong Natural Science Foundation (grants ZR2016CP04 and ZR2017BC040) and the Innovation Project of Shandong Academy of Medical Sciences (grant 201604).
Footnotes
Citation Zong G, Zhong C, Fu J, Zhao Z, Cao G. 2018. Complete genome sequence of the high-natamycin-producing strain Streptomyces gilvosporeus F607. Genome Announc 6:e01402-17. https://doi.org/10.1128/genomeA.01402-17.
REFERENCES
- 1.Ansari Z, Miller D, Galor A. 2013. Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep 7:209–218. doi: 10.1007/s12281-013-0150-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Patterson K, Strek ME. 2010. Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc 7:237–244. doi: 10.1513/pats.200908-086AL. [DOI] [PubMed] [Google Scholar]
- 3.Aparicio JF, Colina AJ, Ceballos E, Martín JF. 1999. The biosynthetic gene cluster for the 26-membered ring polyene macrolide pimaricin. A new polyketide synthase organization encoded by two subclusters separated by functionalization genes. J Biol Chem 274:10133–10139. doi: 10.1074/jbc.274.15.10133. [DOI] [PubMed] [Google Scholar]
- 4.Liang J, Xu Z, Liu T, Lin J, Cen P. 2008 Effects of cultivation conditions on the production of natamycin with Streptomyces gilvosporeus LK-196. Enzyme Microb Technol 42:145–150. doi: 10.1016/j.enzmictec.2007.08.012. [DOI] [PubMed] [Google Scholar]
- 5.Du YL, Chen SF, Cheng LY, Shen XL, Tian Y, Li YQ. 2009. Identification of a novel Streptomyces chattanoogensis L10 and enhancing its natamycin production by overexpressing positive regulator ScnRII. J Microbiol 47:506–513. doi: 10.1007/s12275-009-0014-0. [DOI] [PubMed] [Google Scholar]
- 6.Lu CG, Liu WC, Qiu JY, Wang HM, Liu T, De Liu W. 2008. Identification of an antifungal metabolite produced by a potential biocontrol Actinomyces strain A01. Braz J Microbiol 39:701–707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Beites T, Oliveira P, Rioseras B, Pires SD, Oliveira R, Tamagnini P, Moradas-Ferreira P, Manteca Á, Mendes MV. 2015. Streptomyces natalensis programmed cell death and morphological differentiation are dependent on oxidative stress. Sci Rep 5:12887. doi: 10.1038/srep12887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ju KS, Gao J, Doroghazi JR, Wang KK, Thibodeaux CJ, Li S, Metzger E, Fudala J, Su J, Zhang JK, Lee J, Cioni JP, Evans BS, Hirota R, Labeda DP, van der Donk WA, Metcalf WW. 2015. Discovery of phosphonic acid natural products by mining the genomes of 10,000 actinomycetes. Proc Natl Acad Sci U S A 112:12175–12180. doi: 10.1073/pnas.1500873112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Aparicio JF, Barreales EG, Payero TD, Vicente CM, de Pedro A, Santos-Aberturas J. 2016. Biotechnological production and application of the antibiotic pimaricin: biosynthesis and its regulation. Appl Microbiol Biotechnol 100:61–78. doi: 10.1007/s00253-015-7077-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Du YL, Li SZ, Zhou Z, Chen SF, Fan WM, Li YQ. 2011. The pleitropic regulator AdpAch is required for natamycin biosynthesis and morphological differentiation in Streptomyces chattanoogensis. Microbiology 157:1300–1311. doi: 10.1099/mic.0.046607-0. [DOI] [PubMed] [Google Scholar]
- 11.Wang Y, Tao Z, Zheng H, Zhang F, Long Q, Deng Z, Tao M. 2016. Iteratively improving natamycin production in Streptomyces gilvosporeus by a large operon-reporter based strategy. Metab Eng 38:418–426. doi: 10.1016/j.ymben.2016.10.005. [DOI] [PubMed] [Google Scholar]